Hostname: page-component-7c8c6479df-24hb2 Total loading time: 0 Render date: 2024-03-29T13:52:53.484Z Has data issue: false hasContentIssue false

Anxiety State or Masked Depression?

A Study based on the Action of Monoamine Oxidase Inhibitors

Published online by Cambridge University Press:  29 January 2018

John Pollitt
Affiliation:
St. Thomas' Hospital, London S.E.1
John Young
Affiliation:
The Maudsley Hospital, Denmark Hill, S.E.5

Extract

In 1959, West and Dally reported the effects of iproniazid in depressive syndromes, drawing attention to the greater therapeutic effectiveness of this drug in ‘atypical’ or ‘hysterical’ depressive states than in endogenous depression. Later, Sargant and Dally (1962) found a group of patients with good previous personalities, showing obvious features of depression, whose anxiety symptoms responded to phenelzine alone, but in view of the response of other patients with anxiety they questioned whether monoamine oxidase inhibitors were really antidepressant, or whether they were essentially drugs acting against anxiety. These findings prompted this study, intended to compare other parts of the clinical pictures of anxiety states responsive to monoamine oxidase inhibitors with those of depressive illnesses.

Type
Research Article
Copyright
Copyright © The Royal College of Psychiatrists, 1971 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, E. W., and Trethowan, W. H. (1967). Psychiatry. 2nd Ed. Ballière, Tindall and Cassell. London. p. 168.Google Scholar
Armitage, P. (1955) ‘Tests for linear in proportions and frequencies.’ Biometrics, 11, 375–86.CrossRefGoogle Scholar
Board, F., Wadeson, R., and Persky, H. (1957). ‘Depressive affect and endocrine functions.’ Arch. Neurol. Psychiat., 78, 612–20.Google ScholarPubMed
Cameron, D. E. (1945). ‘Some relationships between excitement, depression and anxiety.’ Amer. J. Psychiat., 102, 385–94.Google Scholar
Cochran, W. G. (1954) ‘Some methods of strengthening the common χ2 tests.’ Biometrics, 10, 417–51.Google Scholar
Curtis, G. C., Cleghorn, R. A., Sourkes, T. L. (1960). ‘The relationship between affect and the excretion of adrenaline, nor-adrenaline, and 17-hydroxy-corticosteroids.’ J. psychosom. Res. 4, 176–84.CrossRefGoogle Scholar
Foulds, G. A. (1960). ‘Psychotic depression and age.’ J. ment. Sci., 106, 1394–97.Google Scholar
Frieze, M. (1965). ‘Depression in children and adolescents.’ Letter to the Ed. Brit. med. J. ii, 1489.Google Scholar
Hordern, A. (1965). Depressive States. Charles C. Thomas. Springfield, Illinois.Google Scholar
Lewis, A. J. (1934). ‘Melancholia: a clinical survey of depressive states.’ J. ment. Sci., 80, 277378.Google Scholar
Mapother, E. (1926). ‘Discussion on manic depressive psychosis.’ Brit. med. J., ii, 872–9.Google Scholar
Miller, P. R. (1969). Sense and Symbol. Staples Press: London.Google Scholar
Pollttt, J. D. (1960). ‘Depression and the functional shift.’ Comp. Psychiat., 1, 381–90.Google Scholar
Rogers, R. H. (1965). In The Scientific Basis of Drug Therapy in Psychiatry. Pergamon Press, Oxford.Google Scholar
Sargant, W., and Dally, P. (1962). ‘Treatment of anxiety states by antidepressant drugs.’ Brit. med. J., i, 69.Google Scholar
Slater, E. (1961). ‘The Thirty-fifth Maudsley Lecture: “Hysteria 311”.’ J. ment. Sci., 107, 359–81.Google Scholar
Walker, L. (1959). ‘The prognosis for affective illness with overt anxiety.’ J. Neurol. Neurosurg. Psychiat., 22, 338–41.CrossRefGoogle ScholarPubMed
West, E., and Dally, P. (1959). ‘Effects of iproniazid in depressive syndromes.’ Brit. med. J., i, 1491–94.Google Scholar
Yates, F. (1948) ‘The analysis of contingency tables with groupings based on quantitative characters’. Biometrika, 35, 176–81.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.